相关产品推荐更多 >

CD11c Antibody, anti-human, PerCP-Vio® 700, REAfinity™, 100 tests in 200 µL
询价
ELK-1 pS383 Antibody, anti-human, FITC, REAfinity™, 30 tests in 60 µL
询价
GM-CSF Antibody, anti-human, APC, 30 tests in 300 µL
询价
CCL2 (MCP-1) Antibody, anti-human/mouse/rat, Vio® B515, REAfinity™, 30 tests in 60 µL
询价
Integrin β7 Antibody, anti-human/mouse, PE-Vio® 615, REAfinity™, 30 tests in 60 µL
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
CD310 (VEGFR-3)
- 亚型:
recombinant human IgG1
- 形态:
Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
- 保存条件:
避光,4-8℃
- 克隆性:
REA419
- 标记物:
Vio Bright V423
- 适应物种:
human
- 保质期:
24个月
- 供应商:
Miltenyi Biotec
- 宿主:
human cell line
- 应用范围:
Flow cytometry
- 浓度:
1:50
- 抗体英文名:
CD310 (VEGFR-3) Antibody, anti-human, REAfinity™
- 抗体名:
CD310 (VEGFR-3) Antibody, anti-human, REAfinity™
- 规格:
100 tests in 200 µL
Identification and enumeration of CD310 (VEGFR-3)+ cells by flow cytometryClone REA419 recognizes the human CD310 antigen, a single-pass type I membrane protein also known as vascular endothelial growth factor receptor 3 (VEGFR-3) or Fms-like tyrosine kinase 4 (FLT-4). CD310 is a tyrosine-protein kinase that acts as a cell-surface receptor for the vascular endothelial growth factors VEGF-C and VEGF-D. It plays an essential role in adult lymph-angiogenesis, in the development of the vascular network, and the cardiovascular system during embryonic development. During early embryogenesis all endothelial cells express CD310, while in the adult tissues, CD310 expression disappears from the vascular endothelial cells and is observed only on the lymphatic endothelium. CD310 plays a major role in tumor growth and metastatic tumor cell dissemination. The receptor is over-expressed on lymphatic vessels in the vicinity of tumors and on the tumor vasculature and therefore may be an excellent target for an effective cancer intervention. | Additional information: Clone REA419 displays negligible binding to Fc receptors.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Achen, M. G. et al. (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. U.S.A. 95 (2): 548–553. | Pajusola, K. et al. (1992) FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res. 52 (20): 5738–5743. | Tammela, T. et al. (2011) VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat. Cell Biol. 13 (10): 1202–1213.
技术资料暂无技术资料 索取技术资料
文献支持
CD310 (VEGFR-3) Antibody, anti-human, Vio® Bright V423, REAfinity™, 100 tests in 200 µL
询价





